Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Yves Zurbuchen"'
Autor:
Carlo Cervia, Yves Zurbuchen, Patrick Taeschler, Tala Ballouz, Dominik Menges, Sara Hasler, Sarah Adamo, Miro E. Raeber, Esther Bächli, Alain Rudiger, Melina Stüssi-Helbling, Lars C. Huber, Jakob Nilsson, Ulrike Held, Milo A. Puhan, Onur Boyman
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-12 (2022)
Studying a prospective cohort, the authors develop and validate a predictive score for post-acute COVID-19 syndrome, also known as long-COVID. This score relies on an immunoglobulin signature and is independent of timepoint of blood sampling.
Externí odkaz:
https://doaj.org/article/79cffcd777124d548463576add3f9a75
Autor:
Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, Akanksha A. Shanbhag, Milos Matkovic, Maira Biggiogero, Pier Andrea Maida, Jacques Moritz, Chiara Toscano, Elaheh Ghovehoud, Raffaello Furlan, Franca Barbic, Antonio Voza, Guendalina De Nadai, Carlo Cervia, Yves Zurbuchen, Patrick Taeschler, Lilly A. Murray, Gabriela Danelon-Sargenti, Simone Moro, Tao Gong, Pietro Piffaretti, Filippo Bianchini, Virginia Crivelli, Lucie Podešvová, Mattia Pedotti, David Jarrossay, Jacopo Sgrignani, Sylvia Thelen, Mario Uhr, Enos Bernasconi, Andri Rauch, Antonio Manzo, Adrian Ciurea, Marco B. L. Rocchi, Luca Varani, Bernhard Moser, Barbara Bottazzi, Marcus Thelen, Brian A. Fallon, Onur Boyman, Alberto Mantovani, Christian Garzoni, Alessandra Franzetti-Pellanda, Mariagrazia Uguccioni, Davide F. Robbiani
Publikováno v:
Muri, Jonathan; Cecchinato, Valentina; Cavalli, Andrea; Shanbhag, Akanksha A; Matkovic, Milos; Biggiogero, Maira; Maida, Pier Andrea; Moritz, Jacques; Toscano, Chiara; Ghovehoud, Elaheh; Furlan, Raffaello; Barbic, Franca; Voza, Antonio; De Nadai, Guendalina; Cervia, Carlo; Zurbuchen, Yves; Taeschler, Patrick; Murray, Lilly A; Danelon-Sargenti, Gabriela; Moro, Simone; ... (2023). Autoantibodies against chemokines post-SARS-CoV-2 infection correlate with disease course. Nature immunology, 24(4), pp. 604-611. Nature Publishing Group 10.1038/s41590-023-01445-w
Infection with severe acute respiratory syndrome coronavirus 2 associates with diverse symptoms, which can persist for months. While antiviral antibodies are protective, those targeting interferons and other immune factors are associated with adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a0f8dec0174a4b1d7107ac5687cdb9f
Autor:
Miro E. Raeber, Dominic Caspar, Yves Zurbuchen, Nannan Guo, Jonas Schmid, Jan Michler, Urs C. Steiner, Andreas E. Moor, Frits Koning, Onur Boyman
Due to its stimulatory potential for immunomodulatory CD4+regulatory T (Treg) cells, low-dose interleukin-2 (IL-2) immunotherapy has recently gained considerable attention for treatment of various autoimmune diseases. Although early-stage clinical tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a46cb8334a6ccf0d7b994a269bb0a5a
https://doi.org/10.1101/2022.11.15.22282201
https://doi.org/10.1101/2022.11.15.22282201
Autor:
Yves Zurbuchen, Jan Michler, Patrick Taeschler, Sarah Adamo, Carlo Cervia, Miro E. Raeber, Ilhan E. Acar, Jakob Nilsson, Michael B. Soyka, Andreas E. Moor, Onur Boyman
B cell responses to different pathogens recruit tailored effector mechanisms, resulting in functionally specialized subsets. For human memory B cells (MBCs), these include CD21+ resting, CD21−CD27+ activated, and CD21−CD27− atypical cells. Whet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c0e4e4f4fcd704af9c532c2a4a12942b
https://doi.org/10.1101/2022.10.07.511336
https://doi.org/10.1101/2022.10.07.511336
Autor:
Sujana Sivapatham, Sarah Adamo, Dominik J. Schaer, Melina Stüssi-Helbling, Stéphane Chevrier, Miro E. Raeber, Esther Baechli, Jakob Nilsson, Lars C. Huber, Andrea Jacobs, Liliane Yang, Alain Rudiger, Carlo Cervia, Bernd Bodenmiller, Onur Boyman, Yves Zurbuchen
Publikováno v:
Allergy
Allergy, 76 (9)
Allergy, 76 (9)
Background Coronavirus disease 2019 (COVID-19) is caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and shows a broad clinical presentation ranging from asymptomatic infection to fatal disease. A very prominent fea
Autor:
Jonathan Muri, Valentina Cecchinato, Andrea Cavalli, Akanksha A. Shanbhag, Milos Matkovic, Maira Biggiogero, Pier Andrea Maida, Jacques Moritz, Chiara Toscano, Elaheh Ghovehoud, Raffaello Furlan, Franca Barbic, Antonio Voza, Guendalina De Nadai, Carlo Cervia, Yves Zurbuchen, Patrick Taeschler, Lilly A. Murray, Gabriela Danelon-Sargenti, Simone Moro, Tao Gong, Pietro Piffaretti, Filippo Bianchini, Virginia Crivelli, Lucie Podešvová, Mattia Pedotti, David Jarrossay, Jacopo Sgrignani, Sylvia Thelen, Mario Uhr, Enos Bernasconi, Andri Rauch, Antonio Manzo, Adrian Ciurea, Marco B.L. Rocchi, Luca Varani, Bernhard Moser, Barbara Bottazzi, Marcus Thelen, Brian A. Fallon, Onur Boyman, Alberto Mantovani, Christian Garzoni, Alessandra Franzetti-Pellanda, Mariagrazia Uguccioni, Davide F. Robbiani
Publikováno v:
bioRxiv
Infection by SARS-CoV-2 leads to diverse symptoms, which can persist for months. While antiviral antibodies are protective, those targeting interferons and other immune factors are associated with adverse COVID-19 outcomes. Instead, we discovered tha
Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures
Autor:
Patrick Taeschler, Carlo Cervia, Yves Zurbuchen, Sara Hasler, Christian Pou, Ziyang Tan, Sarah Adamo, Miro E. Raeber, Esther Bächli, Alain Rudiger, Melina Stüssi‐Helbling, Lars C. Huber, Petter Brodin, Jakob Nilsson, Elsbeth Probst‐Müller, Onur Boyman
Publikováno v:
Allergy. 77(8)
BackgroundSeveral autoimmune features occur during coronavirus disease 2019 (COVID-19), with possible implications for disease course, immunity, and autoimmune pathology. In this study, we longitudinally screened for clinically relevant systemic auto
Autor:
Sarah Adamo, Jan Michler, Yves Zurbuchen, Carlo Cervia, Patrick Taeschler, Miro E. Raeber, Simona Baghai Sain, Jakob Nilsson, Andreas E. Moor, Onur Boyman
Publikováno v:
Nature, 602 (7895)
Immunological memory is a hallmark of adaptive immunity and facilitates an accelerated and enhanced immune response upon re-infection with the same pathogen1,2. Since the outbreak of the ongoing COVID-19 pandemic, a key question has focused on which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06ef024d8f49ebf64c6ca34c4a988391
https://hdl.handle.net/20.500.11850/526401
https://hdl.handle.net/20.500.11850/526401
Autor:
Sarah, Adamo, Jan, Michler, Yves, Zurbuchen, Carlo, Cervia, Patrick, Taeschler, Miro E, Raeber, Simona, Baghai Sain, Jakob, Nilsson, Andreas E, Moor, Onur, Boyman
Publikováno v:
Nature. 602(7895)
Immunological memory is a hallmark of adaptive immunity and facilitates an accelerated and enhanced immune response upon re-infection with the same pathogen
Autor:
Miro E. Raeber, Carlo Cervia, Sarah Adamo, Onur Boyman, Jan Michler, Jakob Nilsson, Patrick Taeschler, Andreas E. Moor, Yves Zurbuchen, Simona Baghai Sain
Immunological memory is a hallmark of adaptive immunity and facilitates an accelerated and enhanced immune response upon re-infection with the same pathogen1,2. Since the outbreak of the ongoing coronavirus disease 19 (COVID-19) pandemic, a key quest
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::38f434ed258f7337547891ecf023014d
https://doi.org/10.1101/2021.07.22.453029
https://doi.org/10.1101/2021.07.22.453029